Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-14 Purchase | 2025-11-17 08:23 am | Niagen Bioscience Inc. | NAGE | Pamir Ozan Chief Financial Officer | 6,685 | $6.8233 | $45,616 | 9,593 (Indirect Direct) | View |
| 2024-11-22 Purchase | 2024-11-25 07:28 am | ChromaDex Corp. | CDXC | Pamir Ozan Chief Financial Officer | 2,907 | $7.36 | $21,397 | 2,907 (Direct) | View |
| 2023-05-18 Purchase | 2023-05-19 08:30 am | 180 Life Sciences Corp. | ATNF | Pamir Ozan CFO | 5,162 | $1.01 | $5,214 | 8,983 (Direct) | View |
| 2021-12-10 Purchase | 2021-12-13 08:31 am | 180 Life Sciences Corp. | ATNF | Pamir Ozan Interim CFO | 3,800 | $3.87 | $14,706 | 76,408 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-12 Option Award | 2025-02-14 6:18 pm | 2026-02-12 2035-02-11 | ChromaDex Corp. | CDXC | Pamir Ozan Chief Financial Officer | 17,230 | $0 | 17,230 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-23 5:04 pm | 2025-10-21 2034-10-20 | ChromaDex Corp. | CDXC | Pamir Ozan Chief Financial Officer | 146,544 | $0 | 146,544 (Direct) | View |
| 2023-09-04 Option Award | 2023-09-06 6:30 pm | N/A 2033-09-04 | 180 Life Sciences Corp. | ATNF | Pamir Ozan CFO | 15,000 | $0 | 23,983 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-03 4:31 pm | N/A 2031-02-26 | 180 Life Sciences Corp. | ATNF | Pamir Ozan Interim CFO | 180,000 | $0 | 252,608 (Direct) | View |